<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03623139</url>
  </required_header>
  <id_info>
    <org_study_id>H-18014918</org_study_id>
    <nct_id>NCT03623139</nct_id>
  </id_info>
  <brief_title>Effects of Basic Carbohydrate Counting Versus Standard Outpatient Nutritional Education: A Trial Focusing on HbA1c and Glucose Variability in Patients With Type 2 Diabetes</brief_title>
  <official_title>Effects of Basic Carbohydrate Counting Versus Standard Outpatient Nutritional Education: A Randomized Controlled Trial Focusing on HbA1c and Glucose Variability in Patients With Type 2 Diabetes (The BCC Study)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Steno Diabetes Center Copenhagen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Copenhagen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Steno Diabetes Center Copenhagen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to examine the health benefits of adding a concept in basic
      carbohydrate counting (BCC) to the routine outpatient nutritional education for adult
      patients with type 2 diabetes.

      The study hypothesis is that training and education in the BCC concept will improve glycaemic
      control either by reducing HbA1c or the average plasma glucose variability more than offering
      the routine dietary care as a stand-alone dietary treatment.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The trial has a parallel-group design with a study duration of 48 weeks for each participant
      (a 6-month intervention period and a 6-month follow-up period). A total of 226 patients will
      be enrolled in the trial. Participants will be randomized to one of two arms: 1) Standard
      medical and dietary care (control group) or 2) Structured training and education in the BCC
      concept in addition to standard medical and dietary care.

      The primary objective is to evaluate the six months effect of structured training and
      education in the BCC concept compared to standard dietary care on glycaemic control as
      assessed by HbA1c or MAGE (mean amplitude of glycaemic excursions).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 28, 2018</start_date>
  <completion_date type="Anticipated">October 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">October 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in HbA1c</measure>
    <time_frame>Baseline, 6 months</time_frame>
    <description>mmol/mol</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in mean amplitude of glycaemic excursions (MAGE)</measure>
    <time_frame>Baseline, 6 months</time_frame>
    <description>mmol/l</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in HbA1c</measure>
    <time_frame>12 months</time_frame>
    <description>mmol/mol</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in body weight</measure>
    <time_frame>Baseline, 6 months, 12 months</time_frame>
    <description>kg</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in low-density lipoprotein cholesterol (LDL-C)</measure>
    <time_frame>Baseline, 6 months, 12 months</time_frame>
    <description>mmol/l</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in high-density cholesterol (HDL-C)</measure>
    <time_frame>Baseline, 6 months, 12 months</time_frame>
    <description>mmol/l</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in total cholesterol (TC)</measure>
    <time_frame>Baseline, 6 months, 12 months</time_frame>
    <description>mmol/l</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in free fatty acids (FFA)</measure>
    <time_frame>Baseline, 6 months, 12 months</time_frame>
    <description>mmol/l</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in triglycerides (TG)</measure>
    <time_frame>Baseline, 6 months, 12 months</time_frame>
    <description>mmol/l</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in diastolic blood pressure</measure>
    <time_frame>Baseline, 6 months, 12 months</time_frame>
    <description>mm Hg</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in systolic blood pressure</measure>
    <time_frame>Baseline, 6 months, 12 months</time_frame>
    <description>mm Hg</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in waist circumference</measure>
    <time_frame>Baseline, 6 months, 12 months</time_frame>
    <description>cm</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in hip circumference</measure>
    <time_frame>Baseline, 6 months, 12 months</time_frame>
    <description>cm</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in total fat free mass</measure>
    <time_frame>Baseline, 6 months</time_frame>
    <description>gram</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in total fat mass</measure>
    <time_frame>Baseline, 6 months</time_frame>
    <description>gram</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in time in range (3.9-10.0 mmol/l)</measure>
    <time_frame>Baseline, 6 months</time_frame>
    <description>percent (%)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in time spent in hypoglycaemia (&lt;3.9 mmol/l)</measure>
    <time_frame>Baseline, 6 months</time_frame>
    <description>percent (%)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change time spent in hyperglycaemia (e.g. &gt;11.1 mmol/l)</measure>
    <time_frame>Baseline, 6 months</time_frame>
    <description>percent (%)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in standard deviation of mean plasma glucose</measure>
    <time_frame>Baseline, 6 months</time_frame>
    <description>mmol/l</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in mathematical literacy</measure>
    <time_frame>Baseline, 6 months, 12 months</time_frame>
    <description>total score or percent (%)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in carbohydrate estimation accuracy</measure>
    <time_frame>Baseline, 6 months, 12 months</time_frame>
    <description>total score or %</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in diet-related quality of life</measure>
    <time_frame>Baseline, 6 months, 12 months</time_frame>
    <description>total score or percent (%)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in perceived competences in diabetes</measure>
    <time_frame>Baseline, 6 months, 12 months</time_frame>
    <description>total score or percent (%)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in degree of autonomy-supportive dietitian</measure>
    <time_frame>Baseline, 6 months, 12 months</time_frame>
    <description>total score or percent (%)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in total energy intake</measure>
    <time_frame>Baseline, 6 months</time_frame>
    <description>kJ/day</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in dietary intake of carbohydrates</measure>
    <time_frame>Baseline, 6 months</time_frame>
    <description>gram/day or percent of total energy (E%)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in dietary intake of total fat</measure>
    <time_frame>Baseline, 6 months</time_frame>
    <description>gram/day or percent of total energy (E%)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in dietary intake of saturated fatty acids (SFA)</measure>
    <time_frame>Baseline, 6 months</time_frame>
    <description>gram/day or percent of total energy (E%)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in dietary intake of monounsaturated fatty acids (MUFA)</measure>
    <time_frame>Baseline, 6 months</time_frame>
    <description>gram/day or percent of total energy (E%)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in dietary intake of polyunsaturated fatty acids (PUFA)</measure>
    <time_frame>Baseline, 6 months</time_frame>
    <description>gram/day or percent of total energy (E%)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in dietary intake of protein</measure>
    <time_frame>Baseline, 6 months</time_frame>
    <description>gram/day or percent of total energy (E%)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in dietary intake of added sugar</measure>
    <time_frame>Baseline, 6 months</time_frame>
    <description>gram/day , % of total energy or %</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in intake of dietary fibre</measure>
    <time_frame>Baseline, 6 months</time_frame>
    <description>gram/day or g/MJ</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Change in physical activity level</measure>
    <time_frame>Baseline, 6 months, 12 months</time_frame>
    <description>total score or percent (%)</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in urinary biomarkers of carbohydrate intake</measure>
    <time_frame>Baseline, 6 months</time_frame>
    <description>percent (%)</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">226</enrollment>
  <condition>Type2 Diabetes</condition>
  <condition>Diabetes Mellitus, Type 2</condition>
  <condition>Glucose Metabolism Disorders</condition>
  <arm_group>
    <arm_group_label>Standard nutritional education</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Control group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>BCC</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Education and training i basic carbohydrate counting (BCC) plus standard nutritional education</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Standard nutritional education</intervention_name>
    <description>Routine dietary care consists of three individual consultations with a trained dietitian. The individual guidance will be in accordance with the dietary guidelines in type 2 diabetes.</description>
    <arm_group_label>Standard nutritional education</arm_group_label>
    <other_name>Routine dietary care in type 2 diabetes</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Basic carbohydrate counting</intervention_name>
    <description>The BCC concept is a group-based program consisting of three group sessions delivered by trained dietitians.</description>
    <arm_group_label>BCC</arm_group_label>
    <other_name>Education in BCC in addition to standard dietary care</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Type 2 diabetes

          -  Diabetes duration; from &gt;12 months

          -  HbA1c between 53 and 97 mmol/mol

          -  Diet or any glucose-lowering medication

          -  Provided voluntary written informed consent

        Exclusion Criteria:

          -  Practicing carbohydrate counting, as judged by the investigator

          -  Participated in a BCC group program within the last two years

          -  Low daily intake of carbohydrates (defined as below 25 E% or 100 g/day), as judged by
             the investigator

          -  Use of open CGM

          -  Use of a Free Libre device

          -  Use of an automated bolus calculator for carbohydrate counting, as judged by the
             investigator

          -  Gastroparesis

          -  Pregnancy or breastfeeding, or plans of pregnancy within the study period

          -  Uncontrolled medical issues, as judged by the investigator

          -  Concomitant participation in other clinical studies

          -  Unable to understand the informed consent and the study procedures
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bettina Ewers, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Steno Diabetes Center Copenhagen</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Bettina Ewers, MSc</last_name>
    <phone>+45 30912997</phone>
    <email>bettina.ewers@regionh.dk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Tina Vilsboell, DMSc</last_name>
    <email>tina.vilsboell.lauritsen.01@regionh.dk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Steno Diabetes Center Copenhagen</name>
      <address>
        <city>Gentofte</city>
        <zip>DK-2820</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bettina Ewers, MSc</last_name>
      <phone>+45 30912997</phone>
      <email>bettina.ewers@regionh.dk</email>
    </contact>
    <investigator>
      <last_name>Bettina Ewers, MSc</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>September 2018</verification_date>
  <study_first_submitted>July 18, 2018</study_first_submitted>
  <study_first_submitted_qc>August 7, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 9, 2018</study_first_posted>
  <last_update_submitted>September 28, 2018</last_update_submitted>
  <last_update_submitted_qc>September 28, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">October 1, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Steno Diabetes Center Copenhagen</investigator_affiliation>
    <investigator_full_name>Bettina Ewers</investigator_full_name>
    <investigator_title>Head of nutrition, MSc</investigator_title>
  </responsible_party>
  <keyword>carbohydrates</keyword>
  <keyword>basic carbohydrate counting</keyword>
  <keyword>diet</keyword>
  <keyword>type 2 diabetes</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
    <mesh_term>Metabolic Diseases</mesh_term>
    <mesh_term>Glucose Metabolism Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

